Home » Authors » Ronald Trahan

Articles by Ronald Trahan

European VCs are bullish about health technology

Sep. 28, 2011

By Ronald Trahan

Disruptive cardio technologies attracting investors' attention

March 23, 2011

By Ronald Trahan

Disruptive technology makes debut at OneMedForum 2011

Jan. 17, 2011

By Ronald Trahan

CEOs are bullish about going public and launching in Europe

Jan. 12, 2011

By Ronald Trahan

Stent experts explore device development options, controversy

Sep. 25, 2009

By Ronald Trahan

Polymers and medical devices are focal point for chemists

Aug. 23, 2007

By Ronald Trahan

Larger financing rounds being raised on higher valuations

March 23, 2006

By Ronald Trahan

Boston MedTech Congress: Larger financing rounds being raised on higher valuations

March 20, 2006

By Ronald Trahan

Neurotech leaders gather at 3rd annual industry symposium

Oct. 1, 2003

By Ronald Trahan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...